SciBase Changes Certified Adviser to Carnegie Investment Bank AB (Publ)
SciBase Changes Certified Adviser to Carnegie Investment Bank AB (Publ)
Vator SecuritiesSTOCKHOLM, Aug. 21, 2024 /PRNewswire/ -- SciBase Holding AB ("SciBase") (STO: SCIB), SciBase, a leading developer of augmented intelligence-based solutions for skin, hereby announces change of Certified Adviser from Vator Securities to Carnegie Investment Bank AB (publ).
斯德哥尔摩，2024年8月21日 /PRNewswire/ — SciBase Holding Ab（“SciBase”）（STO：SCIB），SciBase是基于增强智能的皮肤解决方案的领先开发商，特此宣布将认证顾问从Vator Securities变更为卡内基投资银行Ab（publ）。
SciBase has entered into an agreement with Carnegie Investment Bank AB (publ) regarding the position as Certified Adviser. Carnegie Investment Bank AB (publ) will assume the role of Certified Adviser effective from September 1, 2024. Until then, Vator Securities will continue to act as the Certified Adviser for the company.
SciBase已与卡内基投资银行股份公司（publ）就认证顾问职位达成协议。卡内基投资银行Ab（publ）将从2024年9月1日起担任认证顾问一职。在此之前，Vator Securities将继续担任该公司的注册顾问。
For additional information, please contact:
Pia Renaudin, VD, tel. +46732069802, e-mail: [email protected]
Certified Advisor (CA):
欲了解更多信息，请联系：
Pia Renaudin，VD，电话 +46732069802，电子邮件：[email protected]
认证顾问 (CA)：
Vator Securities
Tel: +46 8 580 065 99
Email: [email protected]
Vator 证券
电话：+46 8 580 065 99
电子邮件：[电子邮件保护]
About SciBase:
关于 SciBase：
SciBase is a global medical technology company, specializing in early detection and prevention in dermatology. SciBase develops and commercializes Nevisense, a unique point-of-care platform that combines AI (artificial intelligence) and advanced EIS technology to elevate diagnostic accuracy, ensuring proactive skin health management.
SciBase 是一家全球医疗技术公司，专门从事皮肤病学的早期发现和预防。SciBase 开发并商业化了 Nevisense，这是一个独特的即时护理平台，它结合了人工智能（人工智能）和先进的 EIS 技术，可提高诊断准确性，确保积极的皮肤健康管理。
Our commitment is to minimize patient suffering, allowing clinicians to improve and save lives through timely detection and intervention and reduce healthcare costs.
我们的承诺是最大限度地减少患者的痛苦，使临床医生能够通过及时的检测和干预来改善和挽救生命，并降低医疗成本。
Built on more than 20 years of research at Karolinska Institute in Stockholm, Sweden, SciBase is a leader in dermatological advancements.
SciBase建立在瑞典斯德哥尔摩卡罗林斯卡研究所20多年的研究基础上，是皮肤病学进步领域的领导者。
The company has been on the Nasdaq First North Growth Market exchange since June 2, 2015. Learn more at . All press releases and financial reports can be found here:
该公司自2015年6月2日起在纳斯达克第一北方成长市场交易所上市。要了解更多，请访问。所有新闻稿和财务报告都可以在这里找到：
This information was brought to you by Cision
这些信息是由 Cision 带给你的
The following files are available for download:
以下文件可供下载：
|
PM_byte CA eng |
|
pm_byte 加州英语 |
